🔎 Trials Near Me

Dachaigh › Lymphoma › North Carolina › Durham

Sgrùdaidhean clionaigeach Lymphoma ann an Durham, NC

Tha 17 sgrùdaidhean airson Lymphoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

A’ fastadhÌre 2
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04083495

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

A’ fastadhÌre 2
  • Duke University, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221500

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

A’ fastadhÌre 1/2
  • Duke University Medical Center, Durham
12 Months – 21 Years · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

A’ fastadhÌre 1/2
  • UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mìle air falbh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT04588922

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

A’ fastadh
  • Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06296368

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

A’ fastadhÌre 1/2
  • University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mìle air falbh
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

A’ fastadhÌre 3
  • Duke Cancer Institute, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

A’ fastadhÌre 2
  • Duke University Medical Center - Division of Hematologic Malignancies, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

A’ fastadhÌre 1
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05131022

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

A’ fastadh
  • North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06860880

Registry of Older Patients With Cancer

A’ fastadhSgrùdadh amharc
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

A’ fastadhÌre 1/2
  • Duke University Medical Center, Duke Cancer Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

A’ fastadhÌre 2
  • University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 18 gu 66 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06859424

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

A’ fastadh
  • Duke Cancer Institute, Durham
Aoisean 18 gu 39 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT06371768

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

A’ fastadhÌre 1
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT04223765

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

A’ fastadhSgrùdadh amharc
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 27 Dàmh 2025 · NCT01137643

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

A’ fastadhÌre 2
  • Durham VA Medical Center, Durham, NC, Durham
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 14 Dàmh 2025 · NCT06520098

Sgrùdaidhean Lymphoma ann am bailtean eile

Sgrùdaidhean eile ann an Durham

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.